Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:EYEG

AB Corporate Bond ETF (EYEG) Price, Holdings, & News

AB Corporate Bond ETF logo

About AB Corporate Bond ETF (NASDAQ:EYEG)

Key Stats

Today's Range
$35.74
$35.74
50-Day Range
$1.59
$2.25
52-Week Range
$1.44
$8.18
Volume
N/A
Average Volume
935,975 shs
Market Capitalization
$25.02 million
Assets Under Management
$24.95 million
Dividend Yield
1.97%
Net Expense Ratio
0.30%
Aggregate Rating
N/A

ETF Overview

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

AB Corporate Bond ETF Expenses

TypeEYEGInvestment Grade ETFsFixed Income ETFsNASDAQ ETFsAll ETFs
Management Fee0.30%0.22%0.33%0.49%0.52%
Other Expenses0.00%0.12%0.26%0.41%0.53%
Total Expense0.30%0.25%0.40%0.63%0.71%
Fee Waiver0.00%-0.14%-0.25%-0.32%-0.57%
Net Expense0.30%0.23%0.36%0.56%0.59%
Receive EYEG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AB Corporate Bond ETF and its competitors with MarketBeat's FREE daily newsletter.

EYEG ETF News Headlines

This Bull Market Indicator called NVDA at $116
Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…
What Economic Factors Influence Corporate Bond Yields?
BUFC AB Conservative Buffer ETF
See More Headlines

EYEG ETF - Frequently Asked Questions

AB Corporate Bond ETF (NASDAQ:EYEG) announced its quarterly earnings results on Thursday, August, 12th. The specialty pharmaceutical company reported ($0.35) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.42) by $0.07.

AB Corporate Bond ETF (EYEG) raised $5 million in an initial public offering on Friday, February 13th 2015. The company issued 800,000 shares at a price of $6.00 per share. Aegis Capital Corp and Chardan Capital Markets acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that AB Corporate Bond ETF investors own include Bausch Health Companies (BHC), MannKind (MNKD), Bristol-Myers Squibb (BMY), Sorrento Therapeutics (SRNE), Idera Pharmaceuticals (IDRA), SCYNEXIS (SCYX) and Novavax (NVAX).

Fund Details

Issuer
AllianceBernstein
Fund Name
AB Corporate Bond ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:EYEG
Inception Date
12/13/2023
Fund Manager
Timothy Kurpis, Bernd Wuebben

Fund Focus

Asset Class
Fixed Income
Benchmark
N/A
Category
Corporate
Focus
Investment Grade
Development Level
Blended Development
Region
Global
Number of Holdings
403

Fund Statistics

Assets Under Management
$24.95 million
Average Daily Volume
$0.00
Discount/Premium
0.10%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
AllianceBernstein L.P.
Custodian
State Street Bank and Trust Company
Distributor
Foreside Fund Services, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
1,100 shs

Miscellaneous

Beta
0.16
Creation Unit
50,000
Creation Fee
$250.00
10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:EYEG) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners